Research ExplorerJournalsEXPERT REV ANTICANC Publications

EXPERT REV ANTICANC - Expert Review of Anticancer Therapy

1 - 9 out of 9Page size: 50

Publications

  1. 2018

  2. Maintenance and continuous therapy for multiple myeloma

    Richardson, P. G., Laubach, J., Gandolfi, S., Facon, T., Weisel, K. & O'Gorman, P., 08.2018, In: EXPERT REV ANTICANC. 18, 8, p. 751-764 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  3. Therapeutic approaches for refractory germ cell cancer

    Oing, C., Seidel, C. & Bokemeyer, C., 04.2018, In: EXPERT REV ANTICANC. 18, 4, p. 389-397 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  4. 2015

  5. Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer

    Aziz, A., Kempkensteffen, C., May, M., Lebentrau, S., Burger, M., Chun, F. K-H. & Brookman-May, S., 06.2015, In: EXPERT REV ANTICANC. 15, 6, p. 649-66 18 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Systemic treatment of vulvar cancer

    Mahner, S., Prieske, K., Grimm, D., Trillsch, F., Prieske, S., von Amsberg, G., Petersen, C., Müller, V., Jänicke, F. & Woelber, L., 06.2015, In: EXPERT REV ANTICANC. 15, 6, p. 629-37 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2013

  8. Adjuvant therapy in node-positive vulvar cancer

    Mahner, S., Trillsch, F., Kock, L., Rohsbach, D., Petersen, C., Krüll, A., Harter, P., Jänicke, F. & Woelber, L., 01.07.2013, In: EXPERT REV ANTICANC. 13, 7, p. 839-44 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. 2012

  10. Novel aspects of therapy with the dual Src and Abl kinase inhibitor bosutinib in chronic myeloid leukemia.

    von Amsberg, G. & Brümmendorf, T., 2012, In: EXPERT REV ANTICANC. 12, 9, p. 1121-1127 9.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. 2010

  12. Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.

    Harter, P., Hilpert, F., Mahner, S., Heitz, F., Pfisterer, J. & Andreas, D. B., 01.01.2010, In: EXPERT REV ANTICANC. 10, 1, p. 81-88 8 p., 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. Clinical management of borderline ovarian tumors.

    Trillsch, F., Mahner, S., Ruetzel, J., Harter, P., Ewald-Riegler, N., Jänicke, F. & Du Bois, A., 2010, In: EXPERT REV ANTICANC. 10, 7, p. 1115-1124 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. 2009

  15. Role of cytoreductive surgery in recurrent ovarian cancer.

    Harter, P., Hilpert, F., Mahner, S., Kommoss, S., Heitz, F. & Andreas, D. B., 2009, In: EXPERT REV ANTICANC. 9, 7, p. 917-922 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review